Synthesis of an Antibacterial Compound for Helicobacter pylori
Project/Area Number |
15K08006
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Natural medicines
|
Research Institution | Yokohama College of Pharmacy |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
増井 悠 横浜薬科大学, 薬学部, 講師 (70714377)
高橋 孝志 横浜薬科大学, 薬学部, 教授 (80110724)
|
Co-Investigator(Renkei-kenkyūsha) |
MASUI Hisashi 横浜薬科大学, 薬学部薬科学科, 講師 (70714377)
|
Project Period (FY) |
2015-04-01 – 2018-03-31
|
Project Status |
Completed (Fiscal Year 2017)
|
Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2017: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2016: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2015: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Keywords | Helicobacter pylori / ビタミンD3 |
Outline of Final Research Achievements |
VDP1 is a selective antibacterial compound that targets Helicobacter pylori and does not act on other typical bacteria. Herein, we provide a straightforward and mild one-pot method for the synthesis of VDP1 from vitamin D3. The yield of VDP1 synthesized by the ruthenium-periodate oxidization of the compound generated from the aza-Diels-Alder reaction of vitamin D3 and 4-phenyl-1,2,4-triazoline-3,5-dione was greater than that produced via direct ruthenium-periodate catalytic oxidation of vitamin D3.
|
Report
(4 results)
Research Products
(10 results)